Medicenna Therapeutics Corp. (TSX:MDNA)

Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	42	53	77	130	61	92
Market Cap Growth	-49.10%	-30.35%	-40.82%	111.36%	-33.17%	-66.08%
Enterprise Value	37	43	47	108	25	68
Last Close Price	0.46	0.64	0.98	1.86	0.88	1.65
PB Ratio	25.38	21.51	4.01	24.95	2.08	4.40
P/TBV Ratio	26.08	21.93	4.03	25.23	2.08	4.42
Debt / Equity Ratio	0.05	0.05	0.01	-	-	-
Net Debt / Equity Ratio	-2.47	-2.47	-1.29	-3.27	-1.14	-0.99
Net Debt / EBITDA Ratio	0.27	0.27	1.21	0.91	2.06	0.92
Net Debt / FCF Ratio	0.34	0.34	1.49	1.04	2.65	0.87
Quick Ratio	1.39	1.39	6.21	6.34	4.95	8.33
Current Ratio	1.52	1.52	6.35	6.66	5.23	8.92
Return on Equity (ROE)	-170.63%	-170.63%	-97.22%	-146.88%	-39.94%	-76.56%
Return on Assets (ROA)	-76.07%	-76.07%	-53.68%	-42.00%	-34.02%	-42.75%
Return on Capital Employed (ROCE)	-750.00%	-750.00%	-85.20%	-114.80%	-55.30%	-107.90%
Earnings Yield	-43.72%	-34.48%	-15.40%	-19.66%	-16.40%	-24.62%
FCF Yield	-42.21%	-33.57%	-21.56%	-12.55%	-20.65%	-25.72%
Buyback Yield / Dilution	-8.51%	-8.51%	-10.10%	-7.57%	-19.25%	-9.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error